Pay in 4 interest-free payments of $7.02 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Presented for research literature review only Han K et al
Coverage at NY Times, front page today and my input to that piece To view or add a comment, sign in Pseudoscience So heres the whole story on why the FDA is endorsing peptides where there is a lack of solid scientific evidence that they have any effect eg on inflammation, weight loss, longeivity Essentially they added 6 people to the decision making committee who had a specific interests in supporting the sale of these peptides
BPC-157 And Recovery from Musculoskeletal Injuries Research on animal models shows that BPC-157 has the potential to improve performance and recovery from injuries
Webster et al., 2016
CagriSema is investigational under FDA review with a decision expected in 2026, not yet approved [4]
US$ 21.53
US$ 22.61
US$ 22.04
US$ 26.20
US$ 26.23
US$ 20.13
